The Online Investor
Specialty Chemicals M&A image Specialty Chemicals M&A » By The Online Investor Staff, updated Sat., Apr. 20, 3:03 AM Recent mergers and acquisitions in the Specialty Chemicals M&A category.

Slide #50. Cabot Corporation NHUMO, S.A.de C.V

Acquirer: Cabot Corporation (NYSE:CBT)
Acquiree: NHUMO, S.A.de C.V
Details: Cabot Corporation (NYSE:CBT) announced that it has entered into an agreement with Grupo Kuo S.A.B. de C.V. (KUOB.MX) to purchase the remaining 60 percent equity of its Mexican carbon black manufacturing joint venture, NHUMO, S.A.de C.V, for $105 million, of which $80 million will be paid upon closing, excluding cash acquired. NHUMO is the leading carbon black producer in Mexico, and the acquisition will strengthen Cabot's global carbon black business. This strategic asset in Mexico will also serve to meet the growing demand for carbon black throughout North America.

Cabot is a global specialty chemicals and performance materials company. Co.'s principal products are reinforcing and specialty carbons, specialty compounds, conductive carbons, carbon nanotubes, fumed metal oxides, inkjet colorants, and aerogel. Co.'s business is organized into two reportable segments: Reinforcement Materials, which includes reinforcing carbons and engineered elastomer composites solutions; and Performance Chemicals, which combines its specialty carbons, battery materials, fumed metal oxides and aerogel product lines into its Performance Additives business as well as combines its specialty compounds and inkjet product lines into its Formulated Solutions business.

CBT SEC Filing Email Alerts Service


Open the CBT Page at The Online Investor »

Company Name: 
Cabot Corp.
Stock buyback: 
CBT buyback
Website: 
www.cabotcorp.com
Sector: 
Specialty Chemicals
Number of ETFs Holding CBT: 
61
Total Market Value Held by ETFs: 
$1.05B
Total Market Capitalization: 
$5.10B
% of Market Cap. Held by ETFs: 
20.56%
 

Open the CBT Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree CBT Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.33 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
CBT Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Specialty Chemicals M&A - Slide 50 of 91 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.